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The Journal of Immunology
The Facultative Intracellular Pathogen Candida glabrata
Subverts Macrophage Cytokine Production and
Phagolysosome Maturation
Katja Seider,* Sascha Brunke,*,† Lydia Schild,* Nadja Jablonowski,* Duncan Wilson,*
Olivia Majer,‡ Dagmar Barz,x Albert Haas,{ Karl Kuchler,‡ Martin Schaller,‖ and
Bernhard Hube*,#
Although Candida glabrata is an important human pathogenic yeast, its pathogenicity mechanisms are largely unknown. Immune
evasion strategies seem to play key roles during infection, since very little inflammation is observed in mouse models. Further-
more, C. glabrata multiplies intracellularly after engulfment by macrophages. In this study, we sought to identify the strategies
that enable C. glabrata to survive phagosome biogenesis and antimicrobial activities within human monocyte-derived macro-
phages. We show that, despite significant intracellular proliferation, macrophage damage or apoptosis was not apparent, and
production of reactive oxygen species was inhibited. Additionally, with the exception of GM-CSF, levels of pro- and anti-
inflammatory cytokines were only marginally increased. We demonstrate that adhesion to and internalization by macrophages
occur within minutes, and recruitment of endosomal early endosomal Ag 1 and lysosomal-associated membrane protein 1
indicates phagosome maturation. However, phagosomes containing viable C. glabrata, but not heat-killed yeasts, failed to recruit
cathepsin D and were only weakly acidified. This inhibition of acidification did not require fungal viability, but it had a heat-
sensitive surface attribute. Therefore, C. glabrata modifies the phagosome into a nonacidified environment and multiplies until the
host cells finally lyse and release the fungi. Our results suggest persistence of C. glabrata within macrophages as a possible immune
evasion strategy. The Journal of Immunology, 2011, 187: 3072–3086.
C
andida glabrata is an emerging pathogen that has be-
come the second most frequent cause (15%) of candidi-
asis after Candida albicans (1, 2). Both species are
usually commensals, existing as part of the normal microbial flora
of human mucosal surfaces, but they are also successful oppor-
tunistic pathogens, causing either superficial or disseminated in-
fections when the normal bacterial flora is disturbed, barriers are
damaged, or when compromised host immunity permits disease.
C. glabrata infections are especially difficult to treat due to high
antifungal resistance (3).
Although translocation mechanisms remain unclear, C. glabrata
is able to access the bloodstream, from where it can disseminate
to internal organs in susceptible patients. Therefore, C. glabrata
must have developed strategies to counteract or bypass mamma-
lian host defense systems, enabling the fungus to cause systemic
disease. Key virulence attributes of C. albicans, such as hyphal
formation and secretion of hydrolases, are thought to be essential
for tissue invasion and persistence (4–6). C. glabrata lacks these
attributes (1), but it can still be reisolated from infected immu-
nocompetent mice over long periods (7). Furthermore, coloniza-
tion of organs in mice causes very little inflammation (7–9).
Additionally, it has been shown that C. glabrata can survive attack
by phagocytes and even replicate within macrophages after en-
gulfment (10–12). This suggests that immune evasion strategies
might play a key role during infection with C. glabrata.
Phagocytic cells of the innate immune system, such as macro-
phages, dendritic cells, and neutrophils, act to eliminate microbial
pathogens from the bloodstream and tissue. Once recognized,
a microbe is quickly engulfed by the phagocyte and enters the
phagocytic pathway. The phagosome then matures via fusion
events with endosomal vesicles, which in turn leads to the exchange
of membrane proteins and finally yields the phagolysosome, an
extremely hostile environment to microbes (13, 14). Inside the
phagolysosome, certain nutrients and trace elements are severely
restricted, accompanied by an increase in acidification. This
activates acidic hydrolases, such as cathepsin D. Furthermore,
during phagosome biogenesis a battery of reactive oxygen species
(ROS) and reactive nitrogen species and antimicrobial peptides is
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transported into the organelle. The combined action of all of these
factors is normally sufficient to kill and degrade most phagocytosed
microbes. Furthermore, phagocytic cells act as immune modulators
by presenting Ags and secreting pro- and anti-inflammatory cyto-
kines and chemokines, recruiting further immune cells and acti-
vating the adaptive arm of the immune system.
Nevertheless, pathogenic microbes have evolved strategies to
counteract the phagocytic attack and to overcome killing by im-
mune cells (14, 15). Many bacterial pathogens have been studied
with great success; far less, however, is known about facultative
intracellular fungi. Histoplasma capsulatum yeasts, for example,
are able to inhibit phagosome acidification following uptake by
macrophages (16–18). C. albicans inhibits phagosome maturation,
preventing the production of ROS and reactive nitrogen species;
this allows survival and final escape via hyphal formation (19–21).
Additionally, C. albicans modulates the immune response in-
directly via manipulating the host’s cytokine response (22, 23).
The capsule of Cryptococcus neoformans has been shown to
mediate macrophage apoptosis and therefore induces a distinct
anti-inflammatory mechanism to kill the phagocyte (24). Cr.
neoformans can also escape macrophages via extrusion/expulsion
(25, 26). The formation of massive vacuoles by the fungus is
followed by extrusion of the phagosomes and the release of the
pathogen. Macrophages and expelled yeast cells appear morpho-
logically normal and remain alive.
Although interactions of these fungal pathogens with immune
cells have been the subject of several studies, the ability of C.
glabrata to survive the attack by phagocytic cells is less well
described. Kaur et al. (11) showed that, despite the morphological
differences, the transcriptional adaptation of C. glabrata within
a murine macrophage-like cell line is highly similar to that of C.
albicans, and they highlighted the requirement of a family of GPI-
linked aspartyl proteases (yapsins) for survival within macro-
phages and for virulence. Degradation and recycling of endoge-
nous cellular components (autophagy) seem to be another in-
tracellular survival strategy for C. glabrata within macrophages
(12). However, the precise mechanisms by which C. glabrata
subverts killing by macrophages are yet unknown and because C.
glabrata mainly attracts mononuclear cells in vivo (7), we sought
to elucidate the interactions of C. glabrata with human monocyte-
derived macrophages (MDMs) in more detail.
We performed a series of experiments to identify mechanisms that
enable the fungus to resist killing and to establish and maintain
infection. Results were evaluated by drawing comparisons to the
nonpathogenic Saccharomyces cerevisiae, a close relative of C.
glabrata, and to the major and well-described dimorphic yeast C.
albicans (27). We analyzed the capacity of C. glabrata to replicate
within MDMs and to induce apoptosis or macrophage damage, the
production of ROS and cytokines by MDMs, as well as the phag-
osome maturation process. Finally, we were interested in whether
C. glabrata has the potential to kill and escape from the phagocyte.
Materials and Methods
Fungal strains and yeast cell culture
C. glabrata wild-type strain ATCC2001, a GFP-expressing C. glabrata
strain (see below), S. cerevisiae strain ATCC9763, C. albicans wild-
type clinical isolate SC5314 (28), and five clinical C. glabrata isolates
(R. Ru¨chel, University of Go¨ttingen, Go¨ttingen, Germany) were routinely
grown overnight in 1% yeast extract, 2% peptone, and 2% dextrose (YPD)
at 37˚C (C. glabrata) or 30˚C (S. cerevisiae and C. albicans) in a shaking
incubator at 180 rpm.
In selected experiments, serum-opsonized C. glabrata cells were used.
YPD overnight cultures were washed with PBS and incubated with 50%
nonimmune human serum at 37˚C for 30 min under shaking (150 rpm) and
washed again several times with PBS. For preparation of heat-killed yeast
cells, 500 ml overnight culture was washed with PBS and incubated at
70˚C for 10 min, followed by several washes with PBS.
Plasmid and strain construction
The GFP-C. glabrata strain was obtained by genomic integration of GFP
(S65T) under the C. glabrata alcohol dehydrogenase promoter (ADHp)
into the endogenous TRP1 locus. Primers used for strain construction are
listed in Table I. GFP-Actt was cut out from pTD125 (29) and cloned via
EcoRI/SalI into pADHpCg (30). A PCR fragment of the endogenous TRP1
gene containing a 59 untranslated region and a fragment of the 39 un-
translated region were amplified from ATCC2001 genomic DNA. ADHp-
GFP-Actt was PCR amplified from the new constructed plasmid with
flanking regions to the 59-Trp and 39 fragments. For construction of the
final transformation cassette, all three fragments (59-Trp, 39, and ADHp-
GFP-Actt) were fused in a separate PCR reaction and transformed into
ATCC2001 trp1D. Correct genomic integration of all fragments was ver-
ified by genomic PCR.
Macrophage culture and infection
Human PBMCs were isolated with Histopaque-1077 (Sigma-Aldrich)
density centrifugation from buffy coats donated by healthy volunteers.
To differentiate PBMCs into monocyte-derived macrophages (MDMs), 23
106 PBMCs/ml were plated in RPMI 1640 media (with L-glutamine and 25
mM HEPES; PAA Laboratories) containing 10% heat-treated FBS (Life
Technologies) in cell culture dishes. Ten nanograms per milliliter M-CSF
(ImmunoTools) was added to the cultures to induce the differentiation of
macrophages. After 5 d at 5% CO2 and 37˚C, nonadherent cells were re-
moved and the purity of MDMs was determined by staining with an anti-
CD14 Ab and flow cytometry. The percentage of CD14-positive cells was
$80%. All experiments were performed with cells isolated from at least
three different donors.
For infection experiments, adherent MDMs were detached with 50 mM
EDTA and plated in flat-bottom 96- or 24-well plates to give a final
concentration of ∼3 3 104 or 2 3 105 MDMs/well, respectively, in RPMI
1640 without serum. For microscopic analysis MDMs were allowed to
adhere to cover slips within a 24-well plate. For some experiments MDMs
were activated by adding 100 U/ml IFN-g (ImmunoTools) 24 h prior to
infection and during infection. If not stated otherwise, the overnight yeast
culture (C. glabrata, S. cerevisiae, or C. albicans) was washed with PBS,
counted using a hemacytometer, and adjusted to the desired concentration
in RPMI 1640 without serum. MDMs were then infected with yeast cells at
a multiplicity of infection (MOI) of 5 unless stated otherwise.
Replication assay
MDMs were infected with the GFP-expressing C. glabrata strain as de-
scribed above and coincubated for 30 min. The culture was washed three
times to remove unbound yeast cells, followed by an additional incubation
step of 3, 8, 12, or 24 h at 5% CO2 and 37˚C. Cells were fixed with 4%
paraformaldehyde for 10 min at 37˚C, stained for 30 min at 37˚C with 25
mg/ml Alexa Fluor 647-conjugated Con A (Molecular Probes) to visualize
nonphagocytosed yeast cells, and mounted cell side down in ProLong Gold
antifade reagent with DAPI (Molecular Probes). The phagocytic index
(number of C. glabrata taken up per 100 MDMs) was assessed by fluo-
rescence microscopy (Leica DM5500B, Leica DFC360) and results were
obtained by analyzing a minimum of 200 MDMs/well.
To quantify yeast intracellular replication, C. glabrata cells were labeled
with 100 mg/ml FITC (Sigma-Aldrich) in carbonate buffer (0.1 M Na2CO3,
0.15 M NaCl [pH 9.0]) for 30 min at 37˚C, followed by washing with PBS.
MDMs, either untreated or activated with 100 U/ml IFN-g (ImmunoTools)
for 24 h, were infected and incubated as described above, fixed, stained
with Con A, and mounted. Because FITC is not transferred to daughter
cells, differentiation of mother and daughter cells was possible and in-
tracellular replication was quantified by counting at least 200 phagocy-
tosed yeast cells and scored for FITC staining or no staining.
Damage assay
The release of lactate dehydrogenase (LDH) into the culture supernatant
was monitored as a measure ofMDMdamage. Experiments were performed
in 96-well plates. For control samples, MDMs were incubated with medium
only or yeast cells were seeded without MDMs. After 24 and 48 h coin-
cubation, culture supernatants were collected and the amount of LDH was
determined using a cytotoxicity detection kit (Roche Applied Science)
according to the manufacturer’s instructions. LDH activity was analyzed
spectrophotometrically at 492 nm and calculated from a standard curve
obtained from dilutions of the LDH control. All experiments were per-
formed in triplicate for each condition.
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Caspase-3 or caspase-7 activity was measured using the Caspase-Glo 3/7
assay (Promega) according to the manufacturer’s instructions. MDMs
were cultured in white 96-well plates and after 3, 8, or 24 h infection the
Caspase-Glo 3/7 reagent was added containing a proluminescent caspse-3/
7 substrate. Upon caspase-3 or caspase-7 activity, the light emitted was
detected in a microplate reader (Tecan Infinite 200) and was proportional
to the amount of caspase-3 or caspase-7 activity. In positive control
experiments, MDMs were treated with 1 mM staurosporine (Sigma-
Aldrich). All samples, performed in triplicate, were normalized to sam-
ples treated with staurosporine for 8 h.
Additionally, induction of apoptosis was detected by Western blot. For
this purpose, MDMs were seeded in 6-well plates at 1 3 106 cells/well.
After 8 h infection with C. glabrata (MOI of 1, 5, or 15) or treatment with
500 nM staurosporine or both, MDMs were lysed with 500 ml RIPA buffer
(50 mM Tris-HCl, 150 mM NaCl, 0.1% SDS [pH 7.5]). The protein
concentration was measured with the RC DC protein assay kit (Bio-Rad)
and 50 mg proteins was separated by SDS-PAGE and electrophoretically
transferred to a polyvinylidene difluoride membrane. The membranes were
blocked with 5% milk powder at room temperature for 1 h and then in-
cubated with the primary anti–caspase-3 Ab (Cell Signaling Technology)
overnight at 4˚C. Subsequently, the membrane was incubated with a HRP-
conjugated anti-rabbit Ab (Santa Cruz Biotechnology) and immunoreac-
tivity was detected by ECL. Between each incubation step membranes
were washed three times with PBS-Tween. All experiments were repeated
twice.
To analyze apoptosis via DNA fragmentation, MDMs were grown in
6-well plates at 1 3 106 cells/well, infected, or treated with 1 mM staur-
osporine. After 8 or 24 h cells were lysed (10 mM Tris/HCl [pH 8.0], 1
mM EDTA, 0.2% Triton X-100, 0.4 mg/ml RNase) and incubated for 30
min at 37˚C. Next, samples were treated with proteinase K (Roche) for 1 h
at 56˚C (200 mM Tris/HCl [pH 8.5], 10 mM EDTA, 0.4 M NaCl, 0.4%
SDS, 200 mg/ml proteinase K) and DNA was pelleted with isopropanol,
washed with 70% ethanol, and dissolved in 100 ml TE buffer (10 mM Tris-
HCl [pH 7.5], 1 mM EDTA). Fifty microliters was loaded on a 2% agarose
gel and electrophoresis was run for 3 h at 100 V. All experiments were
repeated twice.
Cytokine production
MDMs were infected in 24-well plates. LPS (Sigma-Aldrich) was used as
a control and applied at concentration of 1 mg/ml. After 8 and 24 h, samples
of surrounding medium were collected and centrifuged (10 min, 1000 3
g). The amount of TNF-a, IL-1b, IL-6, IL-8, IL-10, GM-CSF, and IFN-g
secreted by MDMs was determined by ELISA according to the manu-
facturer’s protocol (ImmunoTools for IL-6, IL-8, IL-10, and IFN-g;
eBioscience for TNF-a, IL-1b, and GM-CSF). Cytokine levels were de-
termined by measuring spectrophotometrically at 450 nm and calculated
from a standard curve obtained from dilutions of recombinant proteins
(supplied by manufacturer). All experiments were performed in triplicate
and normalized to C. glabrata-infected samples collected after 24 h
coincubation.
Detection of ROS
ROS production was measured by luminol-ECL and all cells and reagents
were prepared in RPMI 1640 without phenol red. MDMs were grown in
white 96-well plates in 100 ml medium per well. Yeast cultures washed in
RPMI 1640 were counted and 50 ml was added to MDMs (according to
a MOI of 1, 10, and 50). For control experiments, MDMs were left un-
treated in 150 ml RPMI 1640, or 100 nM PMA (Sigma-Aldrich) was added
in 50 ml RPMI 1640. For simultaneous addition of yeast cells and PMA to
MDMs, PMA and yeasts were premixed. Fifty microliters of this premix
was added to the MDMs at a final concentration of 100 nM PMA and a
MOI of 10. All samples were prepared in triplicates. Fifty microliters of
a mixture containing 200 mM luminol and 16 U horseradish peroxidase in
RPMI 1640 was immediately added prior to quantification. Luminescence
was measured every 3 min over a 3-h incubation period at 37˚C using
a microplate reader (Tecan Infinite 200) and maximum relative lumines-
cence units were determined for each measurement. All experiments were
performed in triplicates.
Immunofluorescence microscopy
MDMs on cover slips were infected with GFP-expressing C. glabrata,
opsonized C. glabrata, heat-killed C. glabrata, or FITC-labeled human
serum-opsonized zymosan (hSOZ). Synchronization of phagocytosis was
performed by placing the 24-well plate on ice for 15 min until yeast cells
settled. Unbound yeast cells were removed by washing with prewarmed
(37˚C) medium, and phagocytosis was initiated by incubating at 37˚C and
5% CO2. Cover slips were fixed with 4% paraformaldehyde (10 min, 37˚C)
at indicated time points, stained with Alexa Fluor 647-conjugated Con A
(30 min at 37˚C), permeabilized in 0.2% Triton X-100 in PBS (5 min,
room temperature), and blocked with Image-iT FX signal enhancer (Mo-
lecular Probes; 30 min at room temperature). Cells were then incubated
with primary Ab (anti-early endosomal Ag 1 [EEA1] Ab, BD Biosciences;
anti-lysosomal–associated membrane protein 1 [LAMP1] Ab, BD Bio-
sciences; anti-cathepsin D Ab, Santa Cruz Biotechnology) diluted 1:500 in
PBS with 2% BSA for 1 h at room temperature followed by incubation
with the appropriate secondary Alexa Fluor 555-conjugated anti-mouse Ab
(Molecular Probes); finally, cover slips were mounted cell side down in
ProLong Gold antifade reagent with DAPI (Molecular Probes). The per-
centage of colocalization was calculated manually by analyzing a mini-
mum of 200 yeast cells per well under fluorescent light (Leica DM5500B,
Leica DFC360).
Transmission electron microscopy
For transmission electron microscopy, MDMs were grown in 24-well plates
with a polystyrene plastic bottom. C. glabrata was added at a MOI of 5
Table I. Primers used for the GFP-C. glabrata strain construction
Sequence (59 to 39)






Amplification of 59-untranslated region-Trp
OM01F TCTACAGGAATCCGTTGAAGCTTAC
OM01R CACGGCGCGCCTAGCAGCGGCAAAATGGAAATTATAGCATGAATTCATAGC
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and, after 3 h incubation, nonadherent cells were removed by rinsing three
times with PBS. Samples were fixed with Karnovsky fixative (3% para-
formaldehyde, 3.6% glutaraldehyde [pH 7.2]). After centrifugation, the
sediment was embedded in 3.5% agarose at 37˚C, coagulated at room
temperature, and fixed again in Karnovsky fixative. Postfixed samples (1%
OsO4 containing 1.5% potassium ferrocyanide in aqua bidest, 2 h) were
rinsed with distilled water, block stained with uranyl acetate (2% in dis-
tilled water), dehydrated in alcohol (stepwise 50–100%), immersed in
propylenoxide, and embedded in glycide ether (polymerized 48 h at 60˚C;
Serva). Ultrathin sections were examined with a LIBRA 120 transmission
electron microscope (Carl Zeiss SMT) at 120 kV.
Quantification of phagolysosomal fusion
Acidification of the phagosomes was assessed with the acidotropic dye
LysoTracker Red DND-99 (Molecular Probes). LysoTracker (diluted
1:10,000 in RPMI 1640) was added 1 h prior to infection and during the
incubation with yeast cells. Phagocytosis was synchronized as described
above, and control experiments were performed with uninfected cells, cells
inoculated with hSOZ, or 3-mm latex beads (Sigma-Aldrich). After 10, 30,
and 90 min, the cells were fixed, stained with Alexa Fluor 647-conjugated
Con A, and mounted. Two hundred yeast-containing phagosomes were
counted and scored for lysosomal fusion or no fusion.
Phagosomal pH measurements
Viable and heat-killed C. glabrata were FITC labeled (see above) and
washed in PBS prior to infection of MDMs seeded in black 24-well plates
(MOI of 10). After 1 h coincubation, nonadhered yeast cells were removed
by gentle washing with prewarmed (37˚C) PBS, and intracellular pH was
calculated by linear regression analysis from the fluorescence intensity
ratio at Ex495/Ex450 by comparison with a standard curve (31). Standard
curves were generated with MDMs infected with viable or heat-killed
yeasts incubated with buffer of varying pH (PBS/HCl with pH from 4 to
7) containing 50 mM nigericin (Sigma-Aldrich) and the fluorescence in-
tensity ratio at Ex495/Ex450 was determined. All experiments were per-
formed in triplicates.
Microarray experiments
C. glabrata cells from a YPD overnight culture were washed with PBS,
counted, and either incubated in fresh YPD medium (pH 4.5 or 7.0) (1 3
106 cells /ml) for 30 min at 37˚C or added to MDMs in a 6-well plate (MOI
of 5). Infected cells were placed on ice for 15 min (synchronization),
washed with RPMI 1640 to remove unbound yeast cells, and phagocytosis
was induced by incubating for 30 min at 37˚C and 5% CO2. For control
samples, C. glabrata was treated the same way without MDMs. C. glab-
rata cells from liquid culture (YPD cultures and culture without MDMs)
were then centrifuged and the pellet was resuspended in 500 ml AE buffer
(50 mM sodium acetate [pH 5.3], 10 mM EDTA, 1% SDS). Infected
MDMs were lysed by adding 500 ml AE buffer and centrifuged to pellet
phagocytosed yeast cells and to remove host debris and host nucleic acids.
The pellet was also resuspended in 500 ml AE buffer. For RNA extraction,
500 ml 25:24:1 phenol/chloroform/isoamyl alcohol was added to each
sample, vortexed, and heated for 5 min at 65˚C. Samples were frozen at
280˚C, rethawed again, and centrifuged. RNA was precipitated from the
aqueous phase by isopropanol, and RNA quality was checked with an
Agilent bionalalyzer. RNA labeling, microarray hybridization, and data
analysis were performed as described previously (32). Data of phagocy-
tosed C. glabrata were compared with data of samples obtained without
MDMs to filter for genes upregulated upon phagocytosis and not upon any
other condition (e.g., RPMI 1640 medium, CO2). These genes were than
compared with genes upregulated only at pH 4.5 and not at pH 7.0.
Experiments were repeated twice. The microarray data are stored in the
ArrayExpress database of transcription profiles (http://www.ebi.ac.uk/
arrayexpress/; E-MEXP-2973, Interactions of C. glabrata with human
macrophages; E-MEXP-2974, C. glabrata response to pH change).
Inhibitor and killing studies
An overnight culture of C. glabrata was washed and treated with thiolutin
(5 mg/ml; AppliChem), cycloheximide (1 mg/ml; AppliChem), or tunica-
mycin (1 mg/ml; Sigma-Aldrich) for 2 h and, in the case of tunicamycin,
also for 16 h in YPD. Additionally, yeast cells were killed by heating (10
min, 70˚C in PBS), UVC light (0.1 J/cm2), or thimerosal (100 mM, 1 h in
PBS; Sigma-Aldrich). Afterward, yeasts were extensively washed to
remove excess compounds and added immediately to MDMs. After syn-
chronization (see above), MDMs were allowed to phagocytose yeasts for
30 min at 37˚C and 5% CO2. Acidification of the phagosome was moni-
tored by LysoTracker staining as described above. Two hundred yeast-
containing phagosomes were counted and scored for lysosomal colocali-
zation.
Killing and inhibition of growth was verified by plating yeast cells on
YPD agar for at least 3 d and by measuring metabolic activity by the
cleavage of the tetrazolium salt 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-
2H-tetrazolium-5-carboxanilide (XTT). Briefly, 600 ml PBS containing
2 3 105 yeast cells, 350 ng/ml XTT, and 350 ng/ml coenzyme Q were in-
cubated 1 h at 37˚C. Metabolic activity of dead yeast cells was analyzed
spectrophotometrically at 451 nm and normalized to viable yeast cells. All
experiments were performed in triplicate.
Time-lapse microscopy
MDMs were seeded in petri dishes (Ibidi) at a density of 8 3 105 cells
in RPMI 1640 with 1% FBS and infected with C. glabrata. After 30 min
phagocytosis, cells were washed with prewarmed medium to remove ex-
cess yeast cells and further incubated in a plexiglas environment sur-
rounding the microscope, which was kept constant at 37˚C by a heated
stage and heated air unit and 5% CO2. Phase-contrast images were taken
every 5 min with an Axio Observer.Z1 microscope (Zeiss).
Statistical analysis
All experiments were performed with cells isolated from at least three
different donors. Unless otherwise stated, all data are reported as the
means 6 SD. Data were analyzed using two-tailed, unpaired Student t test
for intergroup comparisons. Statistically significant results are indicated as
follows: *p , 0.05, #p , 0.01.
Results
C. glabrata survives macrophage phagocytosis and replicates
intracellularly
C. glabrata prevents killing by macrophages and may therefore
have evolved distinct strategies for intracellular survival (10, 11).
To investigate this phenomenon in more detail, replication of
C. glabrata in human MDMs was assessed. We infected macro-
phages with a GFP-expressing C. glabrata wild-type strain at a C.
glabrata/macrophage ratio of 5:1 (MOI of 5) for 1 h. Unbound
yeast cells were washed away and the number of intracellular
yeasts was assessed microscopically after different incubation
times using differential (inside/outside) staining. Within 3 h, al-
most all yeast cells were phagocytosed (.95%), resulting in
a relatively stable phagocytic index (number of phagocytosed
yeast cells per 100 macrophages) between 3 and 12 h (Fig. 1A).
However, between 12 and 24 h, we observed a 3-fold increase in
the number of internalized yeast cells, which was presumably due
to replication, as virtually no extracellular yeasts were detectable.
Similar results were obtained when macrophages were lysed and
yeast cells were plated on YPD agar plates after each time period
(CFU counting is not shown). To verify that the increase in the
number of internalized yeast cells was indeed due to intracellular
replication, we stained C. glabrata with FITC, a dye that is not
transferred to daughter cells (Fig. 1C). This has proven to be an
ideal tool to quantify replication within host cells. Over time,
replication increased, and by 24 h, .80% of the population inside
macrophages consisted of daughter cells (Fig. 1B). In contrast, we
observed no intracellular replication of the nonpathogenic yeast S.
cerevisiae. To determine whether additional activation of MDMs
could influence replication of C. glabrata, we primed MDMs with
IFN-g (100 U/ml) prior to and during infection; however, this had
no effect on replication within the 24-h time course (Fig. 1B).
C. glabrata and S. cerevisiae elicit similar levels of
macrophage damage
Next, we determined whether uptake and intracellular replication
of C. glabrata causes damage to macrophages. The ability of C.
glabrata, S. cerevisiae, and C. albicans to damage MDMs was
assayed by quantifying the release of LDH in the culture super-
natant at 24 and 48 h postinfection (Fig. 2). Despite rapid
phagocytosis and intracellular replication of C. glabrata within
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MDMs, very little damage to macrophages was measurable after
24 h, and this was only slightly more than the damage caused by
infection with S. cerevisiae. Serum opsonization of C. glabrata
prior to infection did not influence damage. In contrast, C. albi-
cans, which is known to escape macrophages by producing hy-
phae and pseudohyphae (19), induced a significant release of LDH
after 24 h, whereas notable damage by C. glabrata and S. cer-
evisiae required 48 h coincubation. When compared with C.
albicans, the damage caused by C. glabrata and S. cerevisiae at
this time was still significantly lower. Microscopic analysis con-
firmed development of hyphae and escape of C. albicans at this
stage of infection, whereas there was no evidence of escape for C.
glabrata and S. cerevisiae.
C. glabrata does not induce macrophage apoptosis
The induction of host cell apoptosis is one mechanism used by
some pathogenic microorganisms to facilitate intracellular survival,
to escape from phagocytes, or to modulate the inflammatory re-
sponse by phagocytes (33, 34). To test whether C. glabrata can
cause apoptosis of MDMs, we determined the activity of the
effector caspases 3 and 7. As a positive control, MDMs were
stimulated with staurosporine, an ATP-competitive protein kin-
ase inhibitor, which is known to induce apoptosis by activating
caspase-3 (35). As expected, staurosporine-treated MDMs showed
pronounced caspase-3 or caspase-7 activity after 3 h, resulting in a
peak of activation after 8 h coincubation (Fig. 3A). However,
neither C. glabrata (untreated or serum-opsonized) nor S. cer-
evisiae cells induced detectable caspase-3 or caspase-7 activation
at 3, 8, or 24 h postinfection. In contrast, infection with C. albicans
for 24 h was associated with high levels of caspase-3 or caspase-7
activity, which indicates induction of apoptosis by this fungus.
During activation of the apoptotic pathway, caspases undergo
proteolytic processing. The active form of caspase-3 is generated
by cleavage of the 32-kDa proenzyme into subunits of 17 and 12
kDa, which can be detected by Western blot analysis. The addition
of staurosporine to MDMs resulted in the expected caspase-3
cleavage (Fig. 3B). This was not observed postinfection with
FIGURE 1. C. glabrata survives and replicates within macrophages. A, Microscopic quantification of C. glabrata (C.g.) phagocytosed by human MDMs.
MDMs were infected with GFP-expressing C. glabrata for 30 min (MOI of 5), washed, and coincubated for indicated time points. The phagocytic index,
which represents the number of internalized yeast cells per 100 macrophages, increased with time. For each time point a minimum of 200 macrophages
from at least three separate experiments were analyzed. Results shown are the means 6 SD; n $ 3. B, IFN-g activation of MDMs has no impact on C.
glabrata replication. Untreated and IFN-g–treated (100 U/ml) MDMs were infected with FITC-labeled C. glabrata for 30 min (MOI of 5), washed to
remove excess unbound yeasts, and coincubated for 3, 8, 12, and 24 h. Replication was analyzed microscopically (shown in C). For quantification, at least
200 yeast cells per time point were counted and scored for FITC staining or no staining. Results shown are the means 6 SD; n $ 3. C, Representative
fluorescent microscopy images of FITC-labeled C. glabrata (indicated in green) phagocytosed by MDMs after 8 h coincubation. FITC was not transferred
to daughter cells, allowing subsequent identification of daughter cells and determination of yeast replication within MDMs. White arrows illustrate
nonstained intracellular (daughter) yeast cells (outside staining with Con A is indicated in yellow, the merged image additionally shows the nucleus stained
with DAPI in blue). Original magnification 363.
FIGURE 2. Moderate macrophage damage by C. glabrata. The release
of LDH into the supernatant of infected MDMs (MOI of 5) after 24 and
48 h was measured as a marker for host cell damage. C. glabrata (C.g.)
(untreated or serum-opsonized [C.g. opson.]) damaged MDMs to a low
extent, similar to S. cerevisiae (S.c.). The comparison with damage caused
by C. albicans (C.a.) shows significantly lower LDH levels for C. glabrata
and S. cerevisiae at indicated time points. Results shown are the means 6
SD, n $ 3. *p , 0.05, #p , 0.01 compared with C. albicans at indicated
time points (unpaired Student t test).
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C. glabrata, providing further evidence that C. glabrata does not
induce apoptosis in MDMs. To determine whether C. glabrata
does not induce apoptosis, or whether the yeast is able to actively
inhibit apoptotic cell death, MDMs were coincubated with C.
glabrata and staurosporine. In this study, we used the lowest
staurosporine concentration that still induced apoptosis (500 nM).
Because the band pattern from MDMs coincubated with C.
glabrata and stimulated with staurosporine was similar to the
pattern induced by staurosporine alone (Fig 3B), we concluded
that C. glabrata is not capable of repressing staurosporine-induced
apoptosis.
Finally, we determined whether C. glabrata induced DNA
fragmentation of MDMs, another characteristic sign of apoptosis.
Upon treatment with staurosporine, the typical DNA ladder in-
dicative of apoptosis was observed (Supplemental Fig. 1). In
contrast, no DNA fragmentation was detected after coincubation
with C. glabrata or any other yeast species. Therefore, we con-
cluded that C. glabrata was unable to induce apoptosis in human
monocyte-derived macrophages.
Inhibition of proinflammatory cytokine production by
C. glabrata
Cytokines are important mediators of the immune system and
their production is crucial for determining the outcome of fungal
infections (36, 37). Although cytokine release by epithelial cells
coincubated with C. glabrata has been reported before (38, 39), the
cytokine response of macrophages infected with C. glabrata has
not yet been studied. We therefore examined the levels of proin-
flammatory cytokines (IL-1b, IL-6, IL-8, IFN-g, TNF-a, GM-
CSF), as well as the anti-inflammatory cytokine (IL-10), pro-
duced by MDMs infected with C. glabrata. LPS, a potent inducer
of most cytokines, was used as positive control. Although MDM
populations from different donors produced different total cytokine
levels (resulting in high SDs), the pattern of the cytokine profiles
appeared the same. Therefore, all samples were normalized against
supernatants collected from MDMs infected with C. glabrata for
24 h to facilitate interspecies comparison with C. albicans and S.
cerevisiae (Fig. 4) as well as comparison with serum-opsonized or
heat-killed C. glabrata or samples of IFN-g–preactivated MDMs
infected with C. glabrata in a separate experiment (Supplemental
Fig. 2). Ranges of cytokine data are indicated in the legend of Fig.
4. As shown in Fig. 4, after prolonged incubation (24 h), C.
glabrata-infected macrophages produced less proinflammatory
TNF-a, IL-1b, IL-6, IL-8, and IFN-g as compared with those
infected with S. cerevisiae. Similar differences were observed in
comparison with infection with C. albicans. Additionally, the
predominantly anti-inflammatory cytokine IL-10 (40) was also
poorly produced by C. glabrata-infected MDMs when compared
with MDMs exposed to S. cerevisiae. Serum opsonization, IFN-g
treatment, or heat killing did not increase cytokine levels induced
by C. glabrata after 24 h to those induced by S. cerevisiae or C.
albicans, with the exception of IL-10 and IFN-g (Supplemental
Fig. 2). This indicates a generally reduced stimulation of MDMs
by C. glabrata. In contrast, GM-CSF was most strongly produced
by C. glabrata-infected MDMs. Preactivation of MDMs with
IFN-g or heat killing of C. glabrata abolished this effect (Supple-
mental Fig. 2). In summary, C. glabrata failed to induce a pro-
nounced pro- or anti-inflammatory cytokine response in MDMs,
with the notable exception of GM-CSF.
C. glabrata suppresses production of ROS by MDMs
Because cytokine production of MDMs infected with C. glabrata
was low, we reasoned that antimicrobial activities such as ROS
production may also be reduced. ROS production by untreated
and C. glabrata-infected MDMs was measured in real time by
luminol-ECL, a technique that measures intracellular and extra-
cellular ROS (41). We determined differences in ROS production
by MDMs exposed to PMA (a strong inducer of ROS), C. glabrata
(untreated, serum-opsonized, or heat-killed), S. cerevisiae (un-
treated or serum-opsonized), or C. albicans during a time course of
3 h (Fig. 5A). Additionally, IFN-g–preactivated MDMs infected
with C. glabrata were also included. PMA induced a 2.5-fold
increase in ROS production, whereas in comparison with untreated
MDMs, significantly less ROS was released upon infection with
C. glabrata, C. albicans, or S. cerevisiae. For each species, a dose-
dependent decrease of ROS was observed. Neither preopsoniza-
tion nor IFN-g preactivation of MDMs had a significant effect
on ROS repression by C. glabrata. However, heat inactivation of
C. glabrata (although not statistically significant) as well as serum
opsonization of S. cerevisiae (at a MOI of 10) hampered ROS
inhibition. Overall, these data suggest that these yeast species may
actively downregulate ROS production by MDMs.
FIGURE 3. Apoptotic pathways are not induced or blocked by C. glabrata. A, MDMs did not undergo apoptosis upon infection with C. glabrata (C.g.),
serum-opsonized C. glabrata (C.g. opson.), or S. cerevisiae (S.c.) (MOI of 5) at 3, 8, or 24 h. In contrast, compared with untreated controls, treatment with
1 mM staurosporine or infection with C. albicans (C.a.) for 24 h caused apoptosis indicated by significantly increased caspase-3/7 activities. Results shown
are the means 6 SD, n $ 3. *p , 0.05, #p , 0.01 compared with untreated MDMs at indicated time points (unpaired Student t test). B, A caspase-3
Western blot indicated induction of apoptosis in staurosporine (500 nM)-treated MDMs (8 h treatment) by the presences of cleaved caspase-3 fragments
(indicated by arrows at 12 and 17 kDa). Untreated MDMs or MDMs infected with C. glabrata at an MOI of 1, 5, or 15 showed full-length caspase-3 only
(indicated by arrows at 35 kDa), confirming the absence of an induced apoptosis of MDMs. Simultaneous treatment of MDMs with staurosporine and C.
glabrata did not inhibit induction of apoptosis. Results are representative for at least three independent experiments.
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To investigate this further, we analyzed ROS production upon
coincubation of MDMs with PMA and yeast cells at an MOI of 10
(Fig. 5B). Coincubation of MDMs with C. glabrata reduced PMA-
induced ROS production, albeit not significantly. Coincubation of
MDMs with S. cerevisiae or C. albicans significantly inhibited
PMA-induced ROS production (Fig. 5B). Taken together, these
data suggest an ability of all tested yeast species, especially C.
albicans, to actively suppress ROS production by MDMs.
C. glabrata alters phagosome maturation
Because C. glabrata cells are able to survive and replicate within
macrophages (see above), this yeast must either inhibit or divert
the normal process of phagosome maturation or withstand the
hostile environment of the mature phagolysosome. We therefore
analyzed C. glabrata phagocytosis and the C. glabrata–phag-
olysosome maturation process in detail. We first determined the
presence of the EEA1 on C. glabrata-containing phagosomes,
a marker protein for early endosomes. As shown in Fig. 6A and
6B, by 10 min postinfection, a small percentage of phagosomes
containing C. glabrata (untreated, opsonized, or heat-killed) dis-
played EEA1, and this percentage had decreased by 30 min. In
contrast, the percentage of hSOZ-containing phagosomes dis-
playing EEA1 remained relatively constant between 10 and 30
min. Other early endocytic markers (Rab5, transferrin receptor)
were not detectable at 10 min or later, even in positive control
samples (data not shown), suggesting a very rapid phagosome
maturation process in MDMs.
During phagosome maturation, early endocytic components are
replaced with those associated with late endosomes and lysosomes
(e.g., LAMP1). Following 30 and 90 min coincubation of MDMs
with C. glabrata (either untreated, serum-opsonized, or heat-
killed) or with hSOZ, ∼80% of all phagosomes were LAMP1-
positive (Fig. 6A, 6B). Even after 24 h, LAMP1 remained colo-
calized with C. glabrata-containing phagosomes (Fig. 6C), in-
dicating that C. glabrata does not escape from the phagosome to
the cytosol during this period.
Finally, the normal end point of phagosome maturation is fusion
with lysosomes, which is associated with the acquisition of acid
hydrolases such as cathepsin D. Despite constitutive LAMP1 lo-
calization on C. glabrata-containing phagosomes, we observed
aberrant lysosome fusion: whereas 40 and 60% of phagosomes
containing heat-killed C. glabrata or hSOZ were stained positi-
vely for cathepsin D, respectively, significantly fewer phagosomes
containing viable C. glabrata cells displayed this lysosomal marker
at both time points (Fig. 6A, 6B). This suggested that progression
from the late endosomal to the lysosomal stage of C. glabrata-
containing phagosomes was perturbed.
In addition to immunofluorescence microscopy, we also em-
ployed transmission electron microscopy to examine localization
of C. glabrata within MDMs 3 h postinfection. The micrograph in
Fig. 6D shows five representative yeast cells phagocytosed by
an MDM and demonstrates the presence of intact phagosomal
membranes tightly surrounding the yeast cells.
FIGURE 4. Cytokine release following yeast infection. With the exception of GM-CSF, the release of pro- and anti-inflammatory cytokines is generally
lower by C. glabrata-infected macrophages when compared with S. cerevisiae- or C. albicans-infected macrophages. Primary MDMs from different donors
were incubated with 1 mg/ml LPS, C. glabrata (C.g.), S. cerevisiae (S.c.), or C. albicans (C.a.) at an MOI of 5. After 8 and 24 h cytokines were measured in
the supernatant by ELISA. Results shown are the means 6 SD, n $ 3. Note that y-axes of IL-1b and IL-6 are on a logarithmic scale. Cytokine con-
centrations of MDMs coincubated for 24 h with yeast were in the following ranges (minimum and maximum in pg/ml): TNF-a, 1240.8 (C.g.)–2570.7
(C.a.); IL-1b, 57.9 (C.g.)–1064.3 (C.a.); IL-6, 804.7 (C.g.)–1446.9 (S.c.); IL-8, 2491.5 (C.g.)–6166.4 (C.a.); IL-10, 16.0 (C.g.)–63.1 (S.c.); GM-CSF, 60.3
(C.a.)–157.5 (C.g.); IFN-g, 413.8 (C.g.)–730.3 (S.c.).
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C. glabrata replicates within a nonacidic phagosome
Maturing phagosomes are characterized by a steady decrease in pH,
ranging from 6.0 in early endosomes, 5.5–6.0 in late endosomes, to
4.5–5.5 in phagolysosomes. This decrease in pH contributes to the
antimicrobial environment of phagolysosomes and is crucial for
the activation of hydrolytic enzymes (13). Because C. glabrata ap-
peared to inhibit phagolysosome formation (see above), we used
the acidotropic dye LysoTracker Red (DND-99) to examine
phagosome acidification. This membrane-diffusible dye is trapped
within intracellular acidic compartments following protonation
and can therefore be used to visualize phagosomes with a pH
below 5.5–6.0 (42, 43). LysoTracker staining of phagosomes
containing heat-killed C. glabrata, hSOZ, and latex beads was
clearly evident (no background staining due to strong signals
within the phagosome; Fig. 7A), with a peak of colocalization
occurring at 30 min (Fig. 7B). Phagosomes containing viable C.
glabrata yeasts, however, rarely colocalized with this marker
(∼10% at 30 min, with increased background staining due to low
signal intensity). When C. glabrata was preopsonized with hu-
man serum we observed a slightly higher percentage (∼30% after
30 min) of LysoTracker-positive phagosomes. To exclude a strain-
specific effect, we tested five clinical isolates for LysoTracker
colocalization. None of the clinical isolates differed significantly
in the number of acidified phagosome (ATCC2001, 6.52%; isolate
1, 5.44%; isolate 2, 6.85%; isolate 3, 11.78%; isolate 4, 8.45%;
isolate 5, 10.46%).
We next performed genome-wide transcriptional profiles of C.
glabrata cells exposed to media with a pH of 4.5 or 7.0 and yeast
cells ingested by MDMs. Genes upregulated at pH 4.5 versus
pH 7.0 were compared with those upregulated in phagocytosed
yeast cells. Only 5.5% (5 of 90) of pH 4.5 upregulated genes ($2-
fold) were also induced in MDMs, providing further evidence
that C. glabrata cells are not exposed to an acidic environment
within macrophages (Supplemental Table I).
To confirm our LysoTracker staining and gene expression
analyses, we sought to directly determine the phagosomal pH. For
this approach wemade use of the pH-dependent shift in the 495/450
nm fluorescent ratio of FITC (31, 44). MDMs were incubated with
FITC-prestained C. glabrata yeasts cells (either viable or heat-
FIGURE 5. C. glabrata counteracts the oxidative burst by macrophages. A, ROS production by primary MDMs infected with C. glabrata (C.g.), serum-
opsonized C. glabrata (C.g. opson.), S. cerevisiae (S.c.), serum-opsonized S. cerevisiae (S.c. opson.), or C. albicans (C.a.) decreased dose-dependently with
increasing MOI (MOI of 1, 10, or 50) as monitored by luminol-ECL. Preactivation of MDMs with IFN-g (100 U/ml for 24 h) did not affect ROS production
upon infection with C. glabrata. Decreased ROS levels were less pronounced for heat-killed C. glabrata cells, although not significantly different.
Treatment with 100 nM PMA served as a positive control for ROS stimulation. Bar heights represent percentage of untreated controls (MDMs only).
Results that are significantly different from those of untreated controls (MDMS only) are marked (*/#). Furthermore, significantly different results were
obtained for S. cerevisiae in comparison with serum-opsonized S. cerevisiae cells at an MOI of 10 (marked with #, line). Results shown are the means 6
SD; n $ 3. *p , 0.05, #p , 0.01 by unpaired Student t test. B, Yeasts repress PMA-stimulated ROS production. ROS in response to PMA alone or to PMA
plus a simultaneous infection (MOI of 10) with C. glabrata (C.g.), serum-opsonized C. glabrata (C.g. opson.), S. cerevisiae (S.c.), or C. albicans (C.a.) was
measured by luminol-ECL. Bar heights represent percentage of untreated controls (MDMs only). ROS production after coincubation with PMA and either
yeast strain resulted in repressed ROS production, which was, compared with stimulation with PMA alone, significant only in the case of C. albicans.
Results shown are the means 6 SD, n $ 3. *p , 0.05 by unpaired Student t test.
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killed) for 1 h and the pH was calculated by comparison with
a standard curve. The pH of phagosomes containing heat-killed C.
glabrata was ∼5.3 (Fig. 7C), reflecting a mixture of ∼70% acid-
ified phagosomes (with a pH probably ,5.0) and 30% non-
acidified phagosomes as quantified by LysoTracker colocalization
(Fig. 7B). In contrast, the average pH of phagosomes containing
viable yeasts was 6.1. Taken together, these data demonstrate that
C. glabrata-containing phagosomes do not undergo normal acid-
ification.
Inhibition of phagosome acidification is independent of fungal
transcription and translation or glycosylation activities, but it
requires a UV light-indestructible fungal attribute
We next sought to determine which fungal activities are required
for suppression of phagosome maturation. C. glabrata was pre-
treated with a range of inhibitors to selectively block transcription
(thiolutin), translation (cycloheximide), or glycosylation (tunica-
mycin) prior to incubation with MDMs. The effective concen-
trations were first determined by measuring growth in the presence
of all three substances (Supplemental Fig. 3). Following pre-
treatment of C. glabrata, phagosome acidification was determined
by assessing colocalization with the LysoTracker dye. Treatment
with these different inhibitors did not increase the percentage
of LysoTracker-positive phagosomes, suggesting that phagosome
manipulation does not rely on transcriptional or translational
changes in response to phagocytosis (Fig. 8). Furthermore, neither
short- nor long-term inhibition of glycosylation had an effect on
acidification inhibition.
We concluded that inherent attributes or properties of the fungus,
rather than an active response, are more likely to be involved
in acidification inhibition. Although heat killing eliminated acid-
ification suppression, such thermal treatment is known to result
in significant disruption to the fungal cell surface. Because such
surface components may mediate phagosomal acidification inhib-
FIGURE 6. C. glabrata containing phagosomes acquire the early and late endosomal markers EEA1 and LAMP1, but lack the lysosomal marker ca-
thepsin D. A, Representative fluorescent microscopy images 30 min postinfection show a colocalization (white arrows) of C. glabrata-containing phago-
somes with the early endosomal marker EEA1 and the late endosomal/lysosomal marker LAMP1. Acquisition of the lysosomal enzyme cathepsin D is only
partially detectable (white arrows mark colocalization, red arrows mark absence of colocalization). Marker proteins are indicated in red, while GFP-
expressing C. glabrata is indicated in green. To detect nonphagocytosed yeasts, samples were stained with Con A (in yellow, marked with red arrows in
upper row) prior to permeabilization. The merged image additionally shows the nucleus stained with DAPI in blue. B, Colocalization with EEA1 (upper
panel), LAMP1 (middle panel), and cathepsin D (lower panel) was quantified in each experiment for at least 200 phagosomes containing C. glabrata (C.g.),
serum-opsonized C. glabrata (C.g. opson.), heat-killed C. glabrata (C.g. HK), or hSOZ at indicated time points. Statistical analysis was performed in
comparison with viable C. glabrata at indicated time points. Results shown are the means 6 SD; n $ 3. *p , 0.05 by unpaired Student t test. C,
Representative fluorescent microscopy images 24 h postinfection. C. glabrata containing phagosomes remains positive for LAMP1 after 24 h coincubation.
D, Transmission electron micrographs of C. glabrata phagocytosed by primary MDMs 90 min postinfection. The left panel shows an MDM with five
internalized yeasts (red arrows). The red arrow in the magnification (right panel) marks the phagosomal membrane closely surrounding the yeast cell.
Original magnification 32,000 (left panel), 331,500 (right panel).
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ition, we investigated other methods of inactivating the fungus.
We used UVC light, which mainly damages DNA (45), and thi-
merosal, a substance known to inactivate cells without disrupting
or changing the cell surface (46), to kill yeast cells. The absence of
colonies on YPD agar and a residual metabolic activity of 4.9% in
UVC light-killed yeasts and 3.7% in thimerosal-killed yeasts as
compared with 4.7% in heat-killed yeasts in an XTT assay con-
firmed that both treatments blocked C. glabrata metabolic activity
(data not shown).
Phagocytosed thimerosal-killed C. glabrata stained with Lyso-
Tracker to the same extent as heat-killed yeasts (Fig. 8) and the
dye was able to stain the entire phagosome (similar to heat-killed
cells in Fig. 7A). In contrast, most UVC light-killed yeasts re-
sided in nonacidified phagosomes: only ∼15% of phagosomes
colocalized with LysoTracker. Therefore, the observed suppres-
sion of acidification does not require fungal viability and activity,
but potentially a surface factor that is resistant to UVC light.
Intracellular replication results in eventual macrophage lysis
As described above, C. glabrata is able to suppress phagosome
maturation and survives and replicates intracellularly without
eliciting a strong proinflammatory response or causing extensive
macrophage damage. This poses the question if and how C.
glabrata finally escapes from macrophages.
To identify a possible escape mechanism, we investigated the
course of infection by time-lapse microscopy. MDMs were al-
lowed to phagocytose yeast cells for 30 min, followed by intensive
washing to remove unbound yeasts. Subsequent interactions were
monitored for 7 d in the presence of 1% FBS (Fig. 9). Our
observations confirmed that C. glabrata survived and replicated
within macrophages for days, with obvious damage to MDMs first
visible after 2 to 3 d. At this stage, individual MDMs with high
fungal loads tightened and contracted, until finally host cell lysis
occurred, releasing fungal cells into the medium as a clumped mass,
with loose yeasts floating away (Fig. 9A–D). MDMs in close
proximity were still motile and phagocytic (Fig. 9E–G). As time
progressed, MDM lysis continued and the released C. glabrata cells
readily proliferated in the medium (Fig. 9H, 9I).
Discussion
Even though infections caused by C. glabrata are increasingly
common causes of morbidity and mortality, especially in immu-
nocompromised patients (47, 48), relatively little is known about
the pathogenesis of diseases caused by this yeast, as compared
with C. albicans. For example, few virulence attributes of C.
glabrata have been described (1, 11, 12, 32, 49). One remarkable
feature of C. glabrata is its ability to persist for long periods in
mice after transient systemic infection (following i.v. infections),
without killing the animal and without inducing a strong in-
flammatory response. Indeed, even immunocompetent mice do not
clear such C. glabrata infections over the course of several weeks
(7). This suggests that immune evasion is an important aspect of
C. glabrata pathogenicity. This view is supported by observations
FIGURE 7. C. glabrata inhibits phagosomal acidification. A, Heat-killed C. glabrata colocalized with LysoTracker Red (DND-99) (marked with white
arrows in upper row), whereas viable metabolically active C. glabrata did not (marked with white arrows in lower row). LysoTracker staining is shown in
red, while GFP expression (green) was used to visualize yeast cells. Nonphagocytosed yeasts were stained with Con A (in yellow, indicated by red arrows).
The merged image additionally shows the nucleus stained with DAPI in blue. B, Quantitative assessment of LysoTracker colocalization with viable C.
glabrata (C.g.), opsonized C. glabrata (C.g. opson.), heat-killed C. glabrata (C.g. HK), hSOZ, and latex beads (LB) at 10, 30, and 90 min postinfection. For
quantification a minimum of 200 phagosomes were analyzed. Statistical analysis was performed in comparison with viable C. glabrata at indicated time
points. Results shown are the means 6 SD; n $ 3. *p , 0.05, #p , 0.01 by unpaired Student t test. C, The phagosomal pH of heat-killed and viable C.
glabrata was quantified by infecting MDMs with FITC-labeled yeast cells and calculated by linear regression analysis from the fluorescence intensity ratio
at Ex495/Ex450 by comparison with a standard curve. Viable C. glabrata had the ability to repress acidification, whereas heat-killed yeasts did not. Results
shown are the means 6 SD; n $ 3.
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that C. glabrata can survive attack by macrophages and replicates
within these immune cells (10–12).
These studies, which were based on interactions of C. glabrata
with a macrophage cell line, proposed that C. glabrata can adapt
to the harsh internal environment of the phagocyte via transcrip-
tional reprogramming (11) and mobilization of intracellular re-
sources via autophagy (12). However, the mechanisms by which
C. glabrata survives phagocytosis remained unknown. In the
current study we used primary human MDMs to more closely
reflect human infections and dissected the interactions of C.
glabrata with these cells in detail. By analyzing multiple stages
of C. glabrata–macrophage interactions, from initial contact,
phagocytosis, and intracellular proliferation to escape from mac-
rophages, to our knowledge we provide new insights into the
immune evasion strategies of this important human fungal path-
ogen.
Intracellular proliferation of C. glabrata does not trigger
cytotoxicity or apoptosis of macrophages
Following phagocytosis, most C. glabrata cells survived and went
on to proliferate. Although a certain low level of killing of C.
glabrata may occur, indicated by an increase in daughter cell
number but stable phagocytic index between 3 and 12 h, in-
tracellular survival and proliferation were evident at all time
points analyzed. Priming of MDMs with IFN-g, which is known to
enhance candidacidal activity against C. albicans (50, 51), did
not affect intracellular replication of C. glabrata. Furthermore,
opsonization of C. glabrata with serum factors did not alter the
course of infection, intracellular survival, or replication.
Although C. glabrata, the related but apathogenic ascomycete
S. cerevisiae, and C. albicans were all phagocytosed by macro-
phages, the consequences of uptake were dramatically different
among the three species: S. cerevisiae cells were efficiently
killed by macrophages, whereas many cells of C. albicans and
C. glabrata survived and replicated intracellularly. Intracellular
growth of C. albicans is associated with hyphal formation,
piercing of the host membrane by hyphae, and killing of macro-
phages as early as 3 h after phagocytosis (Refs. 19, 52, 53 and
A. Luettich, K. Seider, S. Brunke, and B. Hube, unpublished ob-
servations). In sharp contrast, replication of C. glabrata within
MDMs did not cause any significant cytotoxicity within 48 h,
and macrophages remained viable for long periods. This sug-
gests that C. glabrata can adapt to the normally harsh intracel-
lular environment and has evolved an intracellular survival
strategy, whereas C. albicans adopts a rapid escape strategy.
Moreover, despite intracellular replication of C. glabrata, we
did not observe any sign of apoptosis of MDMs, as neither acti-
vation of effector caspases 3 or 7 nor fragmentation of DNA was
detectable. Inhibition of apoptosis is a known strategy of facul-
tative intracellular microbes, which allows them to persist in-
tracellularly, concealed from other branches of the immune sys-
tem, such as neutrophils and humoral immune components. For
FIGURE 9. C. glabrata survives and replicates
within macrophages for days and finally escapes into
the extracellular space. Time-lapse microscopy dem-
onstrates a coexistence of MDMs and phagocytosed C.
glabrata (indicated by black arrows in A–C) for up to
2–3 d until the first MDMs burst (indicated by black
arrow in D). By this time neighboring macrophages
were still viable and phagocytosed yeast cells were
released by destroyed macrophages (indicated by black
arrows in E–G). At later stages greater numbers of
MDMs burst, releasing their fungal load. Escaped
yeasts were viable and replicated in the media (in-
dicated by black arrows in H and I).
FIGURE 8. Inhibition of acidification is mediated by a UV light-in-
sensitive attribute and does not require fungal activity. Prior to infection, C.
glabrata was either killed by heat (10 min at 70˚C), thimerosal treatment
(100 mM, 1 h), or UVC light (0.1 J/cm2) or treated with thiolutin (tran-
scription inhibitor), cycloheximide (translation inhibitor) or tunicamycin
(glycosylation inhibitor) at indicated concentrations for 2 h or overnight.
The acidification of the phagosomes was quantified 30 min postinfection
by assessing at least 200 phagosomes for colocalization with LysoTracker.
Statistical analysis was performed in comparison with untreated/viable C.
glabrata. Results shown are the means 6 SD; n $ 3. #p , 0.01 by un-
paired Student t test.
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example, the facultative intracellular dimorphic fungus Histo-
plasma capsulatum was shown to delay host cell death of mono-
cytes by inhibiting apoptosis, thereby securing persistence in an
intracellular niche (54). Even though an active repression of ap-
optosis was not apparent for intracellular C. glabrata cells, the
absence of any apoptotic activity is in agreement with an in-
tracellular persistence strategy.
C. glabrata does not elicit production of the major
proinflammatory cytokines
In addition to killing pathogens by phagocytosis, the ability of
macrophages to recruit other types of immune cells to the site of
infection is a critical function. Therefore, many pathogens have
evolved mechanisms to actively manipulate cytokine production of
phagocytes to modify the activity of infected cells and their in-
fluence on noninfected host cells. For example, the morphological
switch of C. albicans from yeast to hyphal growth abolishes TLR4
activation, the receptor responsible for IFN-g production. Instead,
hyphae bind to TLR2 on mononuclear cells and macrophages,
which leads to an increased production of the anti-inflammatory
cytokine IL-10 and thereby to fewer regulatory T cells (23).
In vivo, however, following i.v. infection, C. albicans induces
a fulminant immune response with high cytokine levels and sub-
sequent death of the murine host (55). This is in striking contrast
to infections with C. glabrata, which are characterized by a mild
immune response and long-term survival of mice (7, 9). In this
study, we made similar observations on the cellular level with
purified macrophages with regard to the production of the proin-
flammatory cytokines IL-1b, IL-6, IL-8, TNF-a, and IFN-g.
These cytokines induce anti-Candida effector functions, including
regulation of leukocyte trafficking, immune cell proliferation, and/
or activating oxidative and nonoxidative metabolic responses by
immune cells. All of these cytokines were produced considerably
less by C. glabrata-infected MDMs, in comparison with MDMs
coincubated with S. cerevisiae or C. albicans. This is in agreement
with a study of Aybay and Imir (56), which showed a reduced
potency of C. glabrata to induce TNF-a from peritoneal macro-
phages when compared with various Candida species and S.
cerevisiae. Furthermore, IL-10, an anti-inflammatory cytokine that
inhibits the secretion of proinflammatory cytokines, was also not
induced, suggestive of a generally low stimulation of MDMs by
C. glabrata. The only cytokine that was induced by C. glabrata
was GM-CSF, even though differences to uninfected controls were
only marginal. These data are in agreement with experimental
mice infections, where an upregulation of GM-CSF on day 2
postinfection was observed, although the overall cytokine re-
sponse was low (7). Furthermore, findings of Li et al. (39, 57) and
Schaller et al. (38) suggested that C. glabrata predominantly
induces the release of GM-CSF from epithelial cells, whereas
induction of other proinflammatory cytokines remained low, es-
pecially in comparison with C. albicans. GM-CSF is a potent
activator of macrophages and induces differentiation of precursor
cells as well as the recruitment of macrophages to sites of in-
fection. This may explain the enhanced tissue infiltration of
mononuclear cells, but not neutrophils, observed in vivo (7). Be-
cause of the remarkable ability of C. glabrata to survive and
replicate in macrophages, it is tempting to speculate that luring
more macrophages to the site of infection may even be beneficial
for the fungus and may constitute part of its immune evasion
strategy.
C. glabrata cells repress the production of high ROS levels
Among other antimicrobial activities, phagocytes use the NADPH
oxidase complex-mediated oxidative burst to eliminate pathogens.
A variety of bacterial and fungal pathogens, however, are equipped
with antioxidant enzymes and molecules to avoid generation of
or to counteract the production of ROS. C. albicans, for example,
when exposed to neutrophils, expresses extracellular superoxide
dismutases (Sod4–Sod6) (58). Accordingly, an inactivation of
these detoxifying enzymes leads to severe loss in virulence and
viability inside immune cells (59). The oxidative stress response
of C. glabrata is controlled by the transcription factors Yap1,
Skn7, Msn2, and Msn4 (30, 60, 61), which mediate resistance of
C. glabrata to H2O2 and other oxidants. Additionally, C. glabrata
possesses a catalase (Cta1p) that is required to survive oxidative
stress (although this is dispensable in a mouse model of systemic
infection) (60, 62). In agreement with a previous study, which
showed that C. glabrata can suppress the release of oxidants
during its interaction with a murine macrophage cell line (21), in
this study we demonstrate repression of ROS production by pri-
mary human macrophages. Additionally, our experiments with
MDMs prestimulated with PMA indicate that C. glabrata pre-
dominantly counteracts the oxidative burst by actively detoxifying
ROS, rather than by downregulating its production. The de-
toxification of ROS might therefore be one mechanism that
contributes to the intracellular survival of C. glabrata in macro-
phages. Similarly, C. albicans can reduce ROS production by
macrophages or dendritic cells (21, 63). However, in our study,
even S. cerevisiae was able to suppress ROS levels in macro-
phages, but not to survive, indicating that reduction of ROS alone
is not sufficient for survival within macrophages, and may even
be a general property of yeast. Interestingly, serum opsonization
hampered ROS inhibition by S. cerevisiae and, to a lesser extent,
C. glabrata, suggesting that receptor–ligand pairs involved in the
uptake of serum-opsonized fungal cells may affect ROS levels.
Additionally, patterns observed for heat-inactivated C. glabrata
hint at a heat-labile factor or a yeast activity involved in ROS
repression.
C. glabrata blocks phagolysosome formation and phagosome
acidification
In addition to ROS repression, pathogens may disrupt normal
phagosome maturation. Changing the phagosome fate has been
described for bacteria such as Mycobacterium, Legionella,
Chlamydia, and Listeria spp. and for pathogenic fungi such as
Aspergillus fumigatus, H. capsulatum, Cr. neoformans, and C.
albicans (reviewed in Refs. 14, 15). In this study, we discovered
that C. glabrata controls the process of phagosome maturation
and acidification in human primary macrophages at a distinct
stage. Shortly after sealing, new phagosomes exchange material
with early endosomes, rendering them fusogenic with late endo-
cytic compartments. The recruitment of EEA1 and LAMP1 mar-
ker proteins to phagosomes containing C. glabrata indicated a
normal progression to the early and late endosomal stages. The
presence of a tight phagosome membrane enclosing the yeast
cell was confirmed by electron microscopy, excluding the possi-
bility of fungal escape into the cytoplasm, a survival strategy of
bacteria such as Listeria and Shigella spp. (64). Phagosomes
normally continue to interact with lysosomes, thereby acquiring
a complex mixture of hydrolytic enzymes and an acidic pH of
∼4.5, finally resulting in activation of antimicrobial activities. Our
results indicate that viable C. glabrata alter phagosomal bio-
genesis at this later stage and prevent fusion with lysosomes, as
most phagosomes did not acquire the lysosomal enzyme cathepsin
D at any time tested and did not acidify, when compared with
heat-killed yeast cells or other controls. Inhibition of acidification
is not a strain-specific ability, as five clinical isolates tested in this
study also resided mainly in nonacidified phagosomes (88–95%).
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Opsonization caused a slightly higher percentage of LysoTracker
colocalization, suggesting that Fc and/or complement receptor
activation partially restores normal maturation. Additionally, the
measurement of phagosomal pH with a pH-dependent fluorescent
dye confirmed a much higher pH for phagosomes containing vi-
able yeasts (pH 6.1) than that for heat-killed yeasts (pH 5.3).
These data are in line with transcriptional profiles thta did not
indicate any exposure of intracellular C. glabrata cells to acidic
pH. Thus, C. glabrata resides and replicates in weakly acidified,
cathepsin D-free vesicles, a status that probably contributes to its
survival. A similar ability has been postulated for other pathogenic
fungi, such as C. albicans and H. capsulatum (17, 20). Both
species block the fusion of phagosomes with lysosomes, as lyso-
somal membrane proteins are actively recycled from, and hydro-
lytic compounds are reduced in, their phagosomes. In the case
of H. capsulatum, it is known that reduced accumulation of the
phagolysosomal proton pump, vacuolar ATPase, together with the
activity of the fungal saposin-like calcium-binding protein, which
potentially interacts with host lipids of the phagosome, contributes
to altered phagosome trafficking (18, 65). As all anti-vacuolar
ATPase Abs tested in this study (four in total) bound non-
specifically to the surface of C. glabrata cells (and were thus not
suitable for microscopic analysis; data not shown), it remains
unclear whether C. glabrata may prevent acidification by down-
regulation of vacuolar ATPase.
Because live C. glabrata, but not heat-killed yeasts, inhibited
the acidification of phagosomes, we postulated that this is an
active fungal-driven process. We therefore performed inhibitor
studies to block transcription, translation, and glycosylation. Fungi
were pretreated with appropriate inhibitors prior to infection of
MDMs, and phagosomal acidification was monitored after 30 min
coincubation; this early time point was chosen to avoid a re-
sumption of the blocked activity. However, no significant en-
hancement of LysoTracker colocalization (and thus prevention
of acidification) was apparent when transcription, translation, or
glycosylation was inhibited. Therefore, we propose that a heat-
sensitive surface factor may disturb phagosomal maturation. To
test this hypothesis, it was necessary to kill the fungus without
damaging its cell surface. Killing C. glabrata with thimerosal
turned out to be unsuitable, as the treatment had a negative effect
on cell integrity. However, inactivation of C. glabrata with UVC
light did not prevent inhibition of phagosomal acidification, sug-
gesting that a heat-sensitive, UV light-indestructible surface at-
tribute may be responsible for the observed phenotype.
Although inhibition of phagolysosome maturation has been
observed for C. albicans, H. capsulatum, A. fumigatus, and Cr.
neoformans, the mechanisms employed by these fungi remain
largely unidentified. Although it is completely unknown how C.
albicans causes incomplete phagosome maturation, it has been
suggested that H. capsulatum and Cr. neoformans secrete proteins
and polysaccharides that lead to the formation of abnormal
phagosomes (65–67). A. fumigatus possesses a surface-bound
structure (1,8-dihydroxynaphthalene–like melanin) that has been
proposed to inhibit lysosomal fusion in human MDMs (68).
Bacterial processes that lead to disruptions of phagosome matu-
ration have been studied in greater detail and might provide hints
about the nature of the UV light-indestructible factor of C.
glabrata. For example, roles for glycolipids such as lipoara-
binomannans and cord factor (trehalose dimycolate) of Myco-
bacterium tuberculosis in interference with phagosome maturation
have been reported (69–71). Both glycolipids contain long hy-
drophobic mycolic acid chains, which might intercalate into the
phagosome membrane and change its membrane properties. This
might disturb trafficking or, alternatively, inhibit the recruitment
of factors needed for phagosome progression. Similar molecules
may contribute to the ability of C. glabrata to arrest phagosome
maturation at a prephagolysosomal stage.
Escape from macrophages
Facultative intracellular microbes have developed a number of
strategies to escape from their transient intracellular environment.
One mechanism is to induce apoptosis to kill the host cell without
causing proinflammatory cytokine production, which itself would
attract and activate immune cells. This has been reported for many
bacteria (e.g., Salmonella or Chlamydia spp.; reviewed in Ref. 72)
and also for fungal pathogens such as Cr. neoformans (24).
However, we did not observe signs of apoptosis by C. glabrata-
infected MDMs, indicating that, at least during the early stages
(24 h) of interaction, C. glabrata does not induce apoptosis.
C. albicans is known to switch from a yeast to a filamentous
form, which is required for its escape from macrophages. Con-
sequently, nonfilamentous mutants become trapped within mac-
rophages, even though these cells are still able to replicate (53,
73). The higher destructive potential of C. albicans may result
from several other virulence factors, such as extracellular hydro-
lytic enzymes, which may act as cytolysins in macrophages, di-
rectly inducing cytotoxicity by modifying host cell structures (74).
C. glabrata, in contrast, does not exhibit significant levels of ex-
tracellular protease activity, at least in vitro, and a role for C.
glabrata phospholipases for virulence has not been reported to
date (75, 76). However, Kaur et al. (11) proposed a function of
a family of GPI-linked aspartic proteases (yapsins) for interaction
with host cells and showed their requirement for survival of C.
glabrata within macrophages.
C. glabrata clearly pursues a different strategy than C. albicans,
as escape, even following 48 h, was not observed. However,
staining phagosomes for LAMP1 after 24 h revealed a diffuse and
punctuate pattern. This is in contrast to the smooth and annular
pattern seen for earlier time points and for killed yeasts, sug-
gesting changes in phagosomal membrane integrity. Therefore, we
investigated whether C. glabrata is capable of escaping MDMs
at later stages to disseminate. We used time-lapse microscopy to
follow the interaction of C. glabrata with MDMs in real time and
observed bursting of MDMs and release of viable yeast cells after
3 d. The yeasts continued to replicate in the medium, and a frac-
tion of the escaped population was rephagocytosed by so-far un-
affected neighboring MDMs.
Although the exact mechanism of escape remains unclear at
this time, it is possible that mechanical rupture of host MDMs oc-
curs following a critical increase in fungal burden. Alternatively,
secretion of fungal factors (such as hydrolases), which may either
accumulate over time or which are triggered in a quorum-
dependent mechanism, could disrupt macrophage cellular pro-
cesses, leading to host cell lysis. C. glabratamay also reside within
host cells until age-related death of the macrophage occurs, al-
though this seems unlikely due to the remaining phagocytic ac-
tivity of neighboring MDMs following C. glabrata escape.
We did not observe an extrusion or expulsion mechanism,
identified for Cr. neoformans, by which fungal cells and macro-
phages remain alive even after the release of yeast cells (25, 26):
MDMs clearly burst when releasing C. glabrata cells. The process
is therefore more comparable to cytolysis, an escape mechanism
used by bacterial species such as Chlamydia or Leishmania spp.
(77, 78). In these cases, lysis of host cells is not only the conse-
quence of the expanding bacterial vacuole, but also of the action
of pore-forming proteins or proteolytic digestion rupturing host
cell membranes. Whether C. glabrata produces such molecules (in
addition to yapsins) inside of MDMs or whether tensioning of
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phagosomal membranes is sufficient for fungal escape remains
speculative.
In summary, our data demonstrate that C. glabrata is able to
subvert normal macrophage phagosome maturation, surviving and
replicating within these immune cells for considerable periods of
time without damaging the host cell or eliciting a proinflammatory
immune response. Although possibly mutually beneficial during
commensal carriage, such an interaction may subvert an effective
immune response and clearance during invasive infections. We
therefore propose that C. glabrata exploits the intracellular niche
of the macrophage phagosome as part of an immune evasion and
persistence strategy.
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